Proposed Data Collections Submitted for Public Comment and Recommendations, 6878-6879 [05-2487]
Download as PDF
<![CDATA[
6878
Federal Register / Vol. 70, No. 26 / Wednesday, February 9, 2005 / Notices
ANNUALIZED BURDEN TABLE
Number of respondents
Respondents
Number of responses per
respondent
47
37
4
4
State and Local Health Departments for Child Surveillance .......................................................
State and Local Health Departments for Adult Surveillance .......................................................
Dated: February 1, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Office of
the Chief Science Officer, Centers for Disease
Control and Prevention.
[FR Doc. 05–2486 Filed 2–8–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Centers for Disease Control and
Prevention
[60Day–05BF]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–371–5976 or send
comments to Sandi Gambescia, CDC
Assistant Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
Human Smoking Behavior Study—
New—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background
CDC, National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP) in a joint
venture with the National Center for
Environmental Health (NCEH) proposes
to conduct a study to better understand
patterns of human smoking behavior
across several of the most popular
cigarette categories (ultralight, light, full
flavored menthol and full-flavored nonmenthol) and to determine the level of
exposure to smoke toxins delivered by
these cigarette categories. This is
important because the current method
of measuring constituents that smoke is
via the Federal Trade Commission’s
machine smoking method, which does
not accurately reflect human smoking
patterns. Although there is ample
evidence of the inadequacies and biases
inherent in machine-smoking protocols,
they serve the purpose of ranking
cigarettes smoked under standardized
Average burden per respondent
(in hrs.)
2
2
conditions. Comparison of cigarette
smoke emissions using machinesmoking methods will persevere until
something superior is developed.
Therefore, machine-smoking must be
adequately informed to yield results that
better reflect human smoking behavior.
Funding for this study will come from
both NCCDPHP and NCEH. The Centers
will share responsibilities, with
administrative and technical assistance
coming from NCCDPHP and laboratory
support coming from NCEH.
This is a laboratory-based descriptive
study of smoking behavior and analysis
of biomarkers of exposure for current
adult smokers of a range of cigarette
categories that are representative of the
most commonly smoked U.S. cigarettes.
The goals of this project are to
characterize the range of human
smoking behavior for a variety of
cigarette categories and machinesmoked yields, and to estimate the
levels of biomarkers of exposure with
the various cigarette styles. This study
will assess known indicators of smoking
behavior (ventilation pore-blocking
behavior, puff volume, puff duration,
puff velocity and inter-puff interval) to
determine typical patterns of smoking
behavior.
Measures of exposure will include
expired-air carbon monoxide boost,
assessment of carcinogens, nicotine and
its metabolites in urine, cotinine in
saliva and solanesol in cigarette butts as
an indicator of total smoke exposure.
There are no direct respondent costs
associated with the information
collection for the study. The smoking
behavior and biomarkers of 360 smokers
will be ascertained.
ANNUALIZED BURDEN
No. of respondents
Respondents
Average burden per response
(in hours)
No. of responses per
respondent
Total burden
(in hours)
Screening .........................................................................................................
Clinic Visit 1 .....................................................................................................
Clinic Visit 2 .....................................................................................................
500
360
360
1
1
1
6/60
1.1
1.0
50
198
180
Total ..........................................................................................................
........................
........................
........................
428
VerDate jul<14>2003
16:49 Feb 08, 2005
Jkt 205001
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
E:\FR\FM\09FEN1.SGM
09FEN1
6879
Federal Register / Vol. 70, No. 26 / Wednesday, February 9, 2005 / Notices
Dated: February 1, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Office of
the Chief Science Officer, Centers for Disease
Control and Prevention.
[FR Doc. 05–2487 Filed 2–8–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–05–0006]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
Proposed Project
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–371–5976 or send
comments to Seleda Perryman, CDC
Assistant Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Statement in Support of Application
for Waiver of Inadmissabilty (0920–
0006)—Extension ‘‘National Center for
Infectious Diseases (NCID), Centers for
Disease Control and Prevention (CDC).
Section 212(a)(1) of the Immigration
and Nationality Act states that aliens
with specific health-related conditions
are ineligible for admission into the
United States. The Attorney General
may waive application of this
inadmissibility on health-related
grounds if an application for waiver is
filed and approved by the consular
office considering the application for
visa. NCID Division of Global Migration
and Quarantine uses this application
primarily to collect information to
establish and maintain records of waiver
applicants in order to notify the U. S.
Citizenship and Immigration Services
(USCIS) when terms, conditions and
controls imposed by waiver are not met.
NCID is requesting the extension of this
data for 3 years. There are no costs to
respondents except their time.
ANNUALIZED BURDEN TABLE
Respondents
No. of respondents
No. of responses per
respondent
Average burden per response
(in hours)
Businesses or Organizations ...........................................................................
Total ..........................................................................................................
200
........................
1
........................
10/60
........................
Dated: February 2, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Office of
the Chief Science Officer, Centers for Disease
Control and Prevention.
[FR Doc. 05–2488 Filed 2–8–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Chronic Disease
Prevention and Health Promotion
Conference Support Program;
Correction
A notice announcing the availability
of Fiscal Year 2005 funds to award a
Grant Agreement to Support Chronic
Disease Prevention and Health
Promotion Conferences, PA 05031 was
published in the Federal Register on
November 3, 2004, Volume 69, Number
212, pages 64057–64062. The notice is
corrected as follows:
VerDate jul<14>2003
17:47 Feb 08, 2005
Jkt 205001
On page 64059, first column, under
III.3 Other, Special Requirements, fourth
bullet, delete the bullet that reads,
‘‘Applicants who do not submit a LOI
will not be eligible to submit an
application for review or funding.’’
On page 64059, first column, under
IV.2 Content and Form of Submission,
Letter of Intent (LOI), first paragraph,
delete the first and the fourth sentence
that reads, ‘‘A LOI is required for this
Program Announcement’’ and ‘‘If you
do not submit a LOI, you will not be
allowed to submit an application.’’
On page 64060, first column, under
IV.3 Submission Dates and Times,
change to extend the LOI Deadline Date:
Cycle B: February 14, 2005, delete the
paragraph that reads, ‘‘CDC requires that
you submit a LOI if you intend to apply
for this program. Although the LOI will
not be evaluated, and does not enter
into review of your subsequent
application, failure to submit a timely
LOI will preclude you from submitting
an application.’’ and replace with the
following, ‘‘CDC requests that you send
a LOI if you intend to apply for this
program. Although the LOI is not
required, not binding, and does not
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Total burden
(in hours)
33
33
enter into the review of your subsequent
application, the LOI will be used to
gauge the level of interest in this
program, and to allow CDC to plan the
application review.’’
Dated: February 3, 2005.
William P. Nichols,
Director, Procurement and Grants Office,
Centers for Disease Control and Prevention.
[FR Doc. 05–2493 Filed 2–8–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Office of Community Services Funding
Opportunity
Funding Opportunity Title: Assets for
Independence Demonstration Program.
Announcement Type: Grant-Initial.
Funding Opportunity Number: HHS–
2005–ACF–OCS–EI–0053.
CFDA Number: 93.602.
Category of Funding Activity: Income
Security and Social Services.
E:\FR\FM\09FEN1.SGM
09FEN1
]]>Agencies
[Federal Register Volume 70, Number 26 (Wednesday, February 9, 2005)]
[Notices]
[Pages 6878-6879]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-2487]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-05BF]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-371-5976 or
send comments to Sandi Gambescia, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Human Smoking Behavior Study--New--National Center for Chronic
Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease
Control and Prevention (CDC).
Background
CDC, National Center for Chronic Disease Prevention and Health
Promotion (NCCDPHP) in a joint venture with the National Center for
Environmental Health (NCEH) proposes to conduct a study to better
understand patterns of human smoking behavior across several of the
most popular cigarette categories (ultralight, light, full flavored
menthol and full-flavored non-menthol) and to determine the level of
exposure to smoke toxins delivered by these cigarette categories. This
is important because the current method of measuring constituents that
smoke is via the Federal Trade Commission's machine smoking method,
which does not accurately reflect human smoking patterns. Although
there is ample evidence of the inadequacies and biases inherent in
machine-smoking protocols, they serve the purpose of ranking cigarettes
smoked under standardized conditions. Comparison of cigarette smoke
emissions using machine-smoking methods will persevere until something
superior is developed. Therefore, machine-smoking must be adequately
informed to yield results that better reflect human smoking behavior.
Funding for this study will come from both NCCDPHP and NCEH. The
Centers will share responsibilities, with administrative and technical
assistance coming from NCCDPHP and laboratory support coming from NCEH.
This is a laboratory-based descriptive study of smoking behavior
and analysis of biomarkers of exposure for current adult smokers of a
range of cigarette categories that are representative of the most
commonly smoked U.S. cigarettes. The goals of this project are to
characterize the range of human smoking behavior for a variety of
cigarette categories and machine-smoked yields, and to estimate the
levels of biomarkers of exposure with the various cigarette styles.
This study will assess known indicators of smoking behavior
(ventilation pore-blocking behavior, puff volume, puff duration, puff
velocity and inter-puff interval) to determine typical patterns of
smoking behavior.
Measures of exposure will include expired-air carbon monoxide
boost, assessment of carcinogens, nicotine and its metabolites in
urine, cotinine in saliva and solanesol in cigarette butts as an
indicator of total smoke exposure. There are no direct respondent costs
associated with the information collection for the study. The smoking
behavior and biomarkers of 360 smokers will be ascertained.
Annualized Burden
----------------------------------------------------------------------------------------------------------------
No. of Average burden
Respondents No. of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Screening....................................... 500 1 6/60 50
Clinic Visit 1.................................. 360 1 1.1 198
Clinic Visit 2.................................. 360 1 1.0 180
-----------------
Total....................................... .............. .............. .............. 428
----------------------------------------------------------------------------------------------------------------
[[Page 6879]]
Dated: February 1, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Office of the Chief Science Officer,
Centers for Disease Control and Prevention.
[FR Doc. 05-2487 Filed 2-8-05; 8:45 am]
BILLING CODE 4163-18-P
